Tri Pointe Homes (NYSE:TPH - Get Free Report) is projected to release its Q1 2025 earnings data before the market opens on Thursday, April 24th. Analysts expect Tri Pointe Homes to announce earnings of $0.45 per share and revenue of $713.65 million for the quarter.
Tri Pointe Homes (NYSE:TPH - Get Free Report) last posted its earnings results on Tuesday, February 18th. The construction company reported $1.37 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.30 by $0.07. Tri Pointe Homes had a net margin of 10.36% and a return on equity of 14.34%. The business had revenue of $1.22 billion for the quarter, compared to analyst estimates of $1.22 billion. On average, analysts expect Tri Pointe Homes to post $4 EPS for the current fiscal year and $3 EPS for the next fiscal year.
Tri Pointe Homes Price Performance
Shares of Tri Pointe Homes stock traded up $0.01 on Monday, hitting $29.58. The company's stock had a trading volume of 1,339,959 shares, compared to its average volume of 872,755. The company has a market capitalization of $2.71 billion, a price-to-earnings ratio of 6.12, a price-to-earnings-growth ratio of 0.67 and a beta of 1.44. The firm has a fifty day moving average price of $31.46 and a 200-day moving average price of $36.87. The company has a debt-to-equity ratio of 0.28, a quick ratio of 1.64 and a current ratio of 2.24. Tri Pointe Homes has a 1 year low of $27.90 and a 1 year high of $47.78.
Wall Street Analysts Forecast Growth
A number of brokerages have recently issued reports on TPH. Wedbush reiterated a "neutral" rating and set a $38.00 target price (down previously from $44.00) on shares of Tri Pointe Homes in a research report on Tuesday, February 18th. Seaport Res Ptn raised shares of Tri Pointe Homes from a "hold" rating to a "strong-buy" rating in a report on Thursday, March 6th. Evercore ISI dropped their target price on shares of Tri Pointe Homes from $54.00 to $42.00 and set an "outperform" rating on the stock in a research report on Wednesday, February 19th. Royal Bank of Canada downgraded shares of Tri Pointe Homes from an "outperform" rating to a "sector perform" rating and reduced their price target for the stock from $41.00 to $37.00 in a research report on Wednesday, February 19th. Finally, Oppenheimer decreased their price target on shares of Tri Pointe Homes from $53.00 to $43.00 and set an "outperform" rating on the stock in a research note on Wednesday, February 19th. Four research analysts have rated the stock with a hold rating, two have assigned a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat.com, Tri Pointe Homes has a consensus rating of "Moderate Buy" and a consensus price target of $40.60.
View Our Latest Stock Analysis on TPH
About Tri Pointe Homes
(
Get Free Report)
Tri Pointe Homes, Inc engages in the design, construction, and sale of single-family attached and detached homes in the United States. The company operates through a portfolio of six regional home building brands comprising Maracay in Arizona; Pardee Homes in California and Nevada; Quadrant Homes in Washington; Trendmaker Homes in Texas; TRI Pointe Homes in California, Colorado, and the Carolinas; and Winchester Homes in Maryland and Northern Virginia.
See Also

Before you consider Tri Pointe Homes, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tri Pointe Homes wasn't on the list.
While Tri Pointe Homes currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.